Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-21 Option Award | 2024-06-25 5:40 pm | N/A 2034-06-20 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 26,014 | $0 | 26,014 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:23 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:34 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 104,921 | $0 | 104,921 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 8:00 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 38,895 | $0 | 38,895 (Direct) | View |
Ownership | 2021-04-22 7:12 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Satvat Ali J. Director | 0 | $0 | 0 (Direct) | View |
| 2021-01-26 Option Award | 2021-01-28 8:40 pm | N/A 2030-05-27 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 159,404 | $0 | 159,404 (Direct) | View |
| 2021-01-26 Disposition | 2021-01-28 7:08 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Satvat Ali J. Director | 86,112 | $0 | 0 (Direct) | View |
| 2020-06-02 Option Award | 2020-06-04 7:17 pm | N/A 2030-06-01 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director 10% Owner | 112,422 | $0 | 112,422 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 4:05 pm | N/A 2030-05-27 | Eidos Therapeutics Inc. | EIDX | Satvat Ali J. Director 10% Owner | 21,528 | $0 | 21,528 (Direct) | View |
| 2020-01-10 Option Award | 2020-01-14 5:55 pm | N/A 2030-01-10 | Coherus BioSciences Inc. | CHRS | Satvat Ali J. Director | 20,000 | $0 | 20,000 (Direct) | View |